yingweiwo

Dihydro-5-azacytidine acetate (DHAC acetate; NSC 264880 acetate)

Dihydro-5-azacytidine acetate (DHAC) is a nucleoside analog that can be incorporated into DNA and inhibit DNA methylation.
Dihydro-5-azacytidine acetate (DHAC acetate; NSC 264880 acetate)
Dihydro-5-azacytidine acetate (DHAC acetate; NSC 264880 acetate) Chemical Structure CAS No.: 2470972-18-8
Product category: DNA Methyltransferase
This product is for research use only, not for human use. We do not sell to patients.
Size Price
1mg
5mg
Other Sizes

Other Forms of Dihydro-5-azacytidine acetate (DHAC acetate; NSC 264880 acetate):

  • Dihydro-5-azacytidine (DHAC; NSC 264880)
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
Dihydro-5-azacytidine acetate (DHAC) is a nucleoside analog that can be incorporated into DNA and inhibit DNA methylation. Dihydro-5-azacytidine acetate has anticancer effect.
Dihydro-5-azacytidine acetate (DHAC acetate; NSC 264880 acetate) (CAS#: 2470972-18-8) is the acetate salt form of dihydro-5-azacytidine, with the molecular formula C10H18N4O7 and a molecular weight of 306.27 g/mol. It is a nucleoside analog that is incorporated into DNA and inhibits DNA methylation (DNA methylation). Like its parent compound, it is a DNA methyltransferase inhibitor with antitumor activity. The acetate salt form is often used to improve the solubility and stability of the compound for research purposes. It is a valuable tool for epigenetic research, allowing for the study of how DNA methylation affects gene expression and cellular behavior in the context of cancer and other diseases.
Biological Activity I Assay Protocols (From Reference)
Targets
The primary biological target of DHAC acetate is DNA methyltransferase (DNMT), specifically DNMT1. By incorporating into DNA, it forms a covalent bond with the enzyme, leading to its inactivation. This results in the hypomethylation of DNA and the reactivation of genes that have been silenced by aberrant methylation. This mechanism of action is identical to that of the parent compound, DHAC. The acetate salt does not change the fundamental biological activity of the molecule but may affect its physical properties, such as solubility, which can influence its behavior in in vitro assays.
ln Vitro
Methylation experiments reveal that, in comparison to their respective controls, an LD10 dose of [3H]DHAC causes a 25.06% hypomethylation of DNA in L1210/0 cells and a 46.32% hypomethylation in a deoxycytidine kinase mutant cell line L1210/dCK(-)[2]. When cytidine triphosphate and dihydro-5-azacytidine (DHAC) compete to be incorporated into RNA, ribosome breakdown and aberrant protein synthesis result[1].
The in vitro activity of DHAC acetate is expected to be similar to that of DHAC. It inhibits DNA methylation and exhibits antiproliferative activity against cancer cell lines. The specific IC50 values vary depending on the cell line and the duration of exposure. It has been shown to induce the differentiation of certain leukemia cell lines and to reactivate silenced tumor suppressor genes. The compound's effects on gene expression are typically studied by measuring the reactivation of methylation-silenced genes using quantitative RT-PCR. Its ability to induce apoptosis in cancer cells has also been documented.
ln Vivo
Following an LD10 dose of Dihydro-5-azacytidine (DHAC; 1500 mg/kg) in tumor-bearing mice (injected with L1210/0 cells), the plasma peak concentration reached is 317 μM, and it is removed biexponentially, with a t1/ 2 α of 1.03 h and a t1/2 β of 5 h[2].
Information regarding the in vivo activity of DHAC acetate is limited, but it is expected to be similar to that of the parent compound, DHAC. DHAC has demonstrated antitumor activity in animal models, but its clinical development was hindered by poor bioavailability and rapid deamination. The acetate salt form may have slightly different pharmacokinetic properties. Further studies are needed to fully characterize the in vivo efficacy and pharmacokinetics of this specific salt form. The parent compound's clinical trials provide a background for understanding the potential in vivo behavior of DHAC acetate.
Enzyme Assay
The non-cellular enzyme or receptor binding assay for DHAC acetate involves measuring its ability to inhibit DNA methyltransferase activity. This is typically done using a biochemical assay with purified DNMT1 enzyme and a DNA substrate. The assay measures the transfer of a methyl group from S-adenosylmethionine (SAM) to the DNA. The compound's inhibitory effect is quantified by measuring the reduction in methyl group incorporation. This type of assay is essential for confirming the compound's direct interaction with its target enzyme and for studying its mechanism of action. The acetate counterion is not expected to interfere with the assay.
Cell Assay
The in vitro cellular assay for DHAC acetate involves treating cancer cell lines with various concentrations of the compound. The effect on DNA methylation is assessed by measuring the global level of 5-methylcytosine in DNA using a dot blot assay or by bisulfite sequencing to analyze the methylation status of specific gene promoters. The reactivation of silenced genes is measured by quantitative RT-PCR. Antiproliferative activity is assessed using standard cell viability assays such as MTT. Apoptosis is evaluated using flow cytometry with Annexin V/PI staining. These assays are used to study the epigenetic and anticancer effects of DHAC acetate.
Animal Protocol
The in vivo animal experiment workflow for DHAC acetate has not been widely reported, but it would be similar to that of the parent compound. A common approach would involve the use of a xenograft model in immunodeficient mice. Cancer cells are injected subcutaneously, and once tumors form, DHAC acetate is administered at various doses and routes. Tumor growth is monitored by measuring tumor volume. The effect on DNA methylation in the tumor tissue is assessed by measuring global 5-methylcytosine levels or by analyzing the methylation status of specific genes. These studies would provide data on the pharmacokinetics and pharmacodynamics of this specific salt form.
References

[1]. Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904. J Thorac Oncol. 2008 Apr;3(4):417-21.

[2]. Biochemical pharmacology of 5,6-dihydro-5-azacytidine (DHAC) and DNA hypomethylation in tumor (L1210)-bearing mice. Cancer Chemother Pharmacol. 1988;21(2):117-21.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C10H18N4O7
Molecular Weight
306.27
Exact Mass
306.118
CAS #
2470972-18-8
Related CAS #
Dihydro-5-azacytidine;62488-57-7
PubChem CID
170901610
Appearance
Typically exists as solid at room temperature
Hydrogen Bond Donor Count
6
Hydrogen Bond Acceptor Count
8
Rotatable Bond Count
2
Heavy Atom Count
21
Complexity
380
Defined Atom Stereocenter Count
4
SMILES
CC(=O)O.C1N=C(NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.2651 mL 16.3255 mL 32.6509 mL
5 mM 0.6530 mL 3.2651 mL 6.5302 mL
10 mM 0.3265 mL 1.6325 mL 3.2651 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us